KeyCorp Cuts HealthEquity (NASDAQ:HQY) Price Target to $100.00

HealthEquity (NASDAQ:HQY - Free Report) had its price objective cut by KeyCorp from $110.00 to $100.00 in a research note issued to investors on Wednesday,Benzinga reports. They currently have an overweight rating on the stock.

A number of other research analysts have also recently issued reports on HQY. Barrington Research restated an "outperform" rating and set a $112.00 price objective on shares of HealthEquity in a report on Friday, April 11th. Raymond James raised shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and cut their price objective for the stock from $120.00 to $115.00 in a research report on Tuesday, March 25th. The Goldman Sachs Group cut their price objective on HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a report on Thursday, March 27th. Finally, Wells Fargo & Company lifted their price target on HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a report on Wednesday, February 26th. One investment analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, HealthEquity presently has a consensus rating of "Buy" and an average target price of $111.75.

HealthEquity Price Performance

NASDAQ HQY traded up $2.03 on Wednesday, hitting $84.52. 944,006 shares of the company were exchanged, compared to its average volume of 765,335. HealthEquity has a 1-year low of $65.01 and a 1-year high of $115.59. The company has a market cap of $7.31 billion, a P/E ratio of 77.54, a P/E/G ratio of 1.60 and a beta of 0.49. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The firm has a 50 day moving average of $94.78 and a two-hundred day moving average of $96.30.

Insider Activity at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of the business's stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the sale, the director now directly owns 78,219 shares in the company, valued at approximately $8,704,992.51. The trade was a 6.85 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Michael Henry Fiore sold 8,881 shares of the firm's stock in a transaction dated Friday, April 4th. The stock was sold at an average price of $78.26, for a total value of $695,027.06. Following the completion of the transaction, the executive vice president now owns 56,655 shares of the company's stock, valued at approximately $4,433,820.30. This represents a 13.55 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 20,381 shares of company stock worth $1,781,432. Company insiders own 2.20% of the company's stock.

Institutional Trading of HealthEquity

A number of hedge funds have recently made changes to their positions in the stock. Janney Montgomery Scott LLC lifted its holdings in shares of HealthEquity by 17.3% in the 1st quarter. Janney Montgomery Scott LLC now owns 6,276 shares of the company's stock worth $555,000 after acquiring an additional 924 shares during the last quarter. Vaughan Nelson Investment Management L.P. increased its position in shares of HealthEquity by 10.1% in the first quarter. Vaughan Nelson Investment Management L.P. now owns 835,413 shares of the company's stock valued at $73,826,000 after acquiring an additional 76,950 shares during the period. Wealth Enhancement Advisory Services LLC increased its stake in shares of HealthEquity by 24.7% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 6,380 shares of the company's stock valued at $564,000 after buying an additional 1,265 shares during the period. Aubrey Capital Management Ltd bought a new position in HealthEquity in the 1st quarter worth $2,298,000. Finally, Fifth Third Bancorp boosted its position in HealthEquity by 17.5% during the 1st quarter. Fifth Third Bancorp now owns 955 shares of the company's stock valued at $84,000 after acquiring an additional 142 shares in the last quarter. 99.55% of the stock is owned by institutional investors.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.